InsiderClue
Stocks · Health care · Services-Medical Laboratories

BIODESIX INC

BDSX Clue Score48
United States Fiscal year ends December CIK 0001439725 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Jack W Schuler
12 Aug 2026
10% owner
Buy indirect
15,000
$24.47
$366.99K
Jack W Schuler
11 Aug 2026
10% owner
Buy indirect
13,700
$24.01
$328.91K
Jack W Schuler
10 Aug 2026
10% owner
Buy indirect
13,900
$24.25
$337.03K
Scott Hutton
23 Feb 2026
President & CEO
Sell
1,490
$12.78
$19.04K
Chris Vazquez
23 Feb 2026
Chief Accounting Officer
Sell
211
$12.78
$2.70K
Robin Harper Cowie
23 Feb 2026
CFO, Sec'y & Treasurer
Sell
535
$12.78
$6.83K
Kieran O'Kane
23 Feb 2026
Chief Commercial Officer
Sell
535
$12.78
$6.83K
Gary Anthony Pestano
23 Feb 2026
Chief Development Officer
Sell
556
$12.78
$7.10K
Gary Anthony Pestano
10 Feb 2026
Chief Development Officer
Sell
540
$10.08
$5.45K
Robin Harper Cowie
10 Feb 2026
CFO, Sec'y & Treasurer
Sell
941
$10.08
$9.49K
Scott Hutton
10 Feb 2026
President & CEO
Sell
3,559
$10.08
$35.89K
Chris Vazquez
10 Feb 2026
Chief Accounting Officer
Sell
101
$10.08
$1.02K
Kieran O'Kane
10 Feb 2026
Chief Commercial Officer
Sell
584
$10.08
$5.89K
Jack W Schuler
26 Jan 2026
10% owner
Buy indirect
20,000
$11.80
$236.06K
Jack W Schuler
23 Jan 2026
10% owner
Buy indirect
80,000
$11.81
$944.67K
Jack W Schuler
22 Jan 2026
10% owner
Buy indirect
82,465
$10.96
$903.56K
Robin Harper Cowie
16 Jan 2026
CFO, Sec'y & Treasurer
Sell
298
$8.15
$2.43K
Scott Hutton
16 Jan 2026
President & CEO
Sell
970
$8.15
$7.90K
Kieran O'Kane
16 Jan 2026
Chief Commercial Officer
Sell
298
$8.15
$2.43K
Gary Anthony Pestano
16 Jan 2026
Chief Development Officer
Sell
298
$8.15
$2.43K
Chris Vazquez
16 Jan 2026
Chief Accounting Officer
Sell
83
$8.15
$676.39
Robin Harper Cowie
10 Nov 2025
CFO, Sec'y & Treasurer
Sold after exercise
50
$7.62
$381.00
Scott Hutton
10 Nov 2025
President & CEO
Sold after exercise
189
$7.62
$1.44K
Kieran O'Kane
10 Nov 2025
Chief Commercial Officer
Sold after exercise
25
$7.62
$190.50
Gary Anthony Pestano
10 Nov 2025
Chief Development Officer
Sold after exercise
23
$7.62
$175.26
Chris Vazquez
10 Nov 2025
Chief Accounting Officer
Sold after exercise
13
$7.62
$99.06

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,235
History held since 3 Nov 2020